Objective To review the progress in the features, early cl inical outcomes, and cl inical appl ication of axial lumbar interbody fusion (AxiaLIF) for the minimally invasive treatment of lumbosacral degenerative diseases. Methods The l iterature about the features, early cl inical outcomes, and cl inical appl ication of AxiaLIF for the minimally invasive treatment of lumbosacral degenerative diseases in recent years was reviewed. Results Almost 9 000 procedures performed globally in recent years, AxiaLIF has shown its safety and effectiveness because of high fusion rates, short hospital ization days, and less iatrogenic compl ications in comparison with standard fusion procedures. ConclusionPostoperative long-term outcomes, biomechanics stabil ity, and extended appl ication of AxiaLIF still need a further study,though it suggests an original minimally invasive treatment of lumbosacral degenerative diseases.